Immukine

Interferon gamma‑1b, the active ingredient in Immukine, is a recombinant human interferon presented as a sterile aqueous solution for subcutaneous administration. It functions as an immunostimulant that enhances macrophage activity and promotes a Th1‑type immune response, and is indicated for use in patients with chronic granulomatous disease and severe malignant osteopetrosis.

GNH USA supplies Immukine as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, transplant centres, oncology units and pharmacies worldwide under EU‑authorized marketing status. The company ensures quality and regulatory compliance throughout the supply chain.

Immukine (interferon gamma‑1b) modulates the immune system and is used in disorders characterized by defective phagocyte function or abnormal bone remodeling. - Chronic granulomatous disease: Improves microbial killing by enhancing macrophage activation and restoring oxidative burst capacity. - Severe malignant osteopetrosis: Promotes bone resorption by stimulating osteoclast differentiation and activity, helping to alleviate disease progression.

Interferon gamma‑1b may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Flu‑like syndrome (fever, chills, myalgia) - Injection‑site erythema or pain - Headache - Nausea

Serious or Rare Side Effects: - Hepatic dysfunction (elevated transaminases) - Hematologic abnormalities (anemia, leukopenia) - Severe allergic reactions, including anaphylaxis - Autoimmune phenomena (e.g., lupus‑like syndrome)

Before initiating therapy, clinicians should consider several safety measures. - Monitor liver function: Perform baseline and periodic hepatic enzyme tests. - Monitor complete blood count: Watch for anemia, leukopenia, or thrombocytopenia. - Assess for hypersensitivity: Discontinue if severe allergic reaction occurs. - Use with caution in pregnancy: Potential risk unknown; weigh benefits against risks. - Avoid in patients with active autoimmune disease unless benefits outweigh risks. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Interferon gamma‑1b can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Live attenuated vaccines: May cause uncontrolled infection; avoid concurrent use. - Systemic corticosteroids: Can diminish immunostimulatory effect of interferon gamma.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): May increase bleeding risk; monitor INR. - Antidiabetic agents: Interferon may affect glucose levels; adjust therapy as needed. - Other immunomodulators: May alter immune response; observe clinical response closely.